Biomet lawsuits filed by thousands of affected people in the United States are not without solid ground. Reports say that these legal claims stem from unnecessary health problems, serious injuries, as well as emotional damage that complainants may have not anticipated or have known about their implants. It may come as no surprise if the numbers are not declining, albeit continuously showing an upsurge, not only against Biomet but as well as other companies who produce similar hip replacement implants.
Controversies surrounding major hip implant manufacturers in the country are deep-rooted. They go way back over a decade hounding these companies to this day. One of these is the controversial product recall conducted by Biomet, alongside other seven medical device manufacturers, in 2000s.
The major hip replacement recall consequently follows a move by France-based medical device company, St. Gobain Desmarquest, which was initiated in view of an unacceptably high fracture rate demonstrated by the firm’s product. The product, which manufactured in early 1998, was a zirconia ceramic femoral head used as a component of hip prostheses distributed by Biomet and other hip implant makers. The component has been found fracturing at a rate greater than initially anticipated in a number of hip implant recipients, particularly within the first 13 to 27 months after device implantation.
In an announcement released by the US Food and Drug Administration in September 2001, Biomet Inc., along with DePuy Orthopaedics, Osteoimplant Technology, Stryker Howmedica Osteonics, Apex Surgical, Smith & Nephew, Encore Orthopedics, and Zimmer, have also subsequently expressed their intent to pull out affected hip implants comprising the aforementioned femoral heads from the market.
Despite the high-profile recall, lawsuits involving Biomet hip products and controversies tied to hip replacement devices have not reportedly ceased to grow. In recent years, an adverse effect after another is experienced by numerous hip implant recipients. Health problems, such as metallosis and soft-tissue damage, that precipitate serious medical consequences have been increasingly reported to the FDA, and have caused quite a stir in various medical communities, consumer advocate groups, and the general public. Personal injury law firms, including the Rottenstein Law Group at rotlaw.com, have also shown their support by establishing informative resource centers easily accessible to people concerned and interested.